“…However, even when survival is improved with TIV, ALS follows a persistent and progressive disease course, and patients with ALS using TIV have to cope with advancing motor disabilities and communication impairments that can impact their quality of life. 11 Patients with ALS living with TIV often display non-motor clinical manifestations over a long disease course, including macroglossia, 12,13 autonomic dysfunction, [14][15][16] glucose intolerance or hyperglycemia, 17,18 infection, 8,16 gall bladder or urinary stones, 19 and decubitus ulcers. 20,21 These may affect the quality of life and survival time of patients; however, their prevalence is unknown.…”